Form 4 for RLMD RELMADA THERAPEUTICS, INC.
Accepted 2022-04-05 00:00:00 ET · period of report 2022-04-01 · accession 0001213900-22-018207 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-05 | 2022-04-01 | RLMD | CASAMENTO CHARLES J | Dir | M - OptEx | $3.24 | +19.8K | 19.8K | New | +$64.2K |
| DM | 2022-04-05 | 2022-04-01 | RLMD | CASAMENTO CHARLES J | Dir | S - Sale+OE | $29.00 | -19.8K | 13.2K | -60% | -$574.2K |
| D | 2022-04-05 | 2022-04-01 | RLMD | CASAMENTO CHARLES J | Dir | M - OptEx | $0.00 | +19.8K | 77.5K | +34% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | M | A | 19,800 | $3.24 | 19,800 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-01 | S | D | 3,300 | $29.00 | 0 | D | — | — | |
| 3 | Common | Common Stock | 2022-04-01 | S | D | 3,300 | $29.00 | 3,300 | D | — | — | |
| 4 | Common | Common Stock | 2022-04-01 | S | D | 3,300 | $29.00 | 6,600 | D | — | — | |
| 5 | Common | Common Stock | 2022-04-01 | S | D | 3,300 | $29.00 | 9,900 | D | — | — | |
| 6 | Common | Common Stock | 2022-04-01 | S | D | 3,300 | $29.00 | 16,500 | D | — | — | |
| 7 | Common | Common Stock | 2022-04-01 | S | D | 3,300 | $29.00 | 13,200 | D | — | — | |
| 8 | Derivative | Stock Option (right to buy) | 2022-04-01 | M | A | 19,800 | $0.00 | 77,511 | D | $3.24 · 2017-10-20 to 2027-10-20 | 19,800 Common Stock | (F2) The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period.. |